Literature DB >> 21358685

Hematopoietic SCT for adult T-cell leukemia/lymphoma: a review.

M Jabbour1, H Tuncer, J Castillo, J Butera, T Roy, J Pojani, M Al-Malki, A S Al-Homsi.   

Abstract

Adult T-cell leukemia/lymphoma is a T-cell malignancy caused by the human T-cell lymphotropic virus type 1. The aggressive forms of the disease carry a poor prognosis with standard therapies. The role of high-dose treatment with blood and marrow transplantation has, therefore, been examined mainly by Japanese groups in the form of retrospective studies. In this study, we review the literature, discuss some of the challenges facing successful transplantation approaches and stress the need for more innovative studies including in the Western hemisphere.

Entities:  

Mesh:

Year:  2011        PMID: 21358685     DOI: 10.1038/bmt.2011.27

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

1.  Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation.

Authors:  Tomohiko Kamimura; Toshihiro Miyamoto; Noriaki Kawano; Akihiko Numata; Yoshikiyo Ito; Yong Chong; Koji Nagafuji; Takanori Teshima; Shin Hayashi; Koichi Akashi
Journal:  Int J Hematol       Date:  2012-04-06       Impact factor: 2.490

2.  Exploration of mRNAs and miRNA classifiers for various ATLL cancer subtypes using machine learning.

Authors:  Mohadeseh Zarei Ghobadi; Rahman Emamzadeh; Elaheh Afsaneh
Journal:  BMC Cancer       Date:  2022-04-21       Impact factor: 4.638

3.  A specific mode of microsatellite instability is a crucial biomarker in adult T-cell leukaemia/lymphoma patients.

Authors:  Kaname Miyashita; Kei Fujii; Kenichi Taguchi; Mototsugu Shimokawa; Mitsuaki A Yoshida; Yasunobu Abe; Jun Okamura; Shinya Oda; Naokuni Uike
Journal:  J Cancer Res Clin Oncol       Date:  2016-10-25       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.